Palivizumab, pneumococcal and influenza vaccination in cystic fibrosis
Authors:
Open Access
- 15 July 2009
- journal article
- other
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 102 (1_suppl) , 23-28
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Indirect Effect of 7‐Valent Pneumococcal Conjugate Vaccine on Pneumococcal Colonization among Unvaccinated Household MembersClinical Infectious Diseases, 2008
- Influenza vaccination coverage in patients with cystic fibrosis followed at 12 care centers in the Greater South Region of France for the season 2005/2006Vaccine, 2008
- The role of respiratory viruses in cystic fibrosisJournal of Cystic Fibrosis, 2008
- Use of Palivizumab for Prevention of Hospitalization as a Result of Respiratory Syncytial Virus in Infants With Cystic FibrosisThe Pediatric Infectious Disease Journal, 2008
- Prophylaxis against respiratory syncytial virus in young children with cystic fibrosisPediatric Pulmonology, 2007
- Ten years of viral and non-bacterial serology in adults with cystic fibrosisEpidemiology and Infection, 2007
- Preimmunization Anti-Pneumococcal Antibody Levels Are Protective in a Majority of Patients With Cystic FibrosisPediatrics, 2001
- Vaccines for preventing influenza in people with cystic fibrosis2000
- Respiratory viral infection predisposing for bacterial disease: a concise reviewFEMS Immunology & Medical Microbiology, 1999
- Association of Respiratory Viral Infections with Pulmonary Deterioration in Patients with Cystic FibrosisNew England Journal of Medicine, 1984